By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Addex Therapeutics 

12, Chemin Des Aulx
1228 Plan-les-Ouates
Geneva      Switzerland
Phone: 41-22-884-1555 Fax: 41-22-884-1556




Company News
Addex Therapeutics (ADXN.SW) Collaborators Published New Data Supporting The Role Of Negative Allosteric Modulators Of Follicle Stimulating Hormone And Luteinizing Hormone Receptors In Reproductive Health 9/20/2016 9:14:43 AM
Addex Therapeutics (ADXN.SW) ADX71441 Demonstrates Positive Results In Highly Translational Preclinical Model Of Spasticity 7/27/2016 9:33:32 AM
LifeSci Capital Issues Equity Research Report On Addex Therapeutics (ADXN.SW) 7/20/2016 9:35:11 AM
Addex Therapeutics (ADXN.SW) Shareholders Approved All Board Proposals At 2016 Annual General Meeting 6/24/2016 9:04:29 AM
Addex Therapeutics (ADXN.SW) mGluR4 And mGluR7 Programs Demonstrate Potential In Preclinical Models Of Neurodegenerative And Psychiatric Diseases 6/13/2016 9:25:51 AM
Addex Therapeutics (ADXN.SW) ADX71441 Demonstrates Positive Results In Non-Human Primate Model Of Cocaine Addiction 6/9/2016 12:38:54 PM
Van Leeuwenhoeck Issues Research Note On Addex Therapeutics (ADXN.SW) 6/8/2016 11:34:46 AM
Addex Therapeutics (ADXN.SW) Annual General Meeting Scheduled For 23 June 2016 6/2/2016 9:16:37 AM
Addex Therapeutics (ADXN.SW) Dipraglurant Positive Phase 2 Data In PD-LID Published In Leading Peer Reviewed Journal Of The Movement Disorder Society 6/2/2016 9:10:32 AM
Addex Therapeutics (ADXN.SW) Increases Issued Share Capital And Creates Treasury Shares 5/31/2016 10:09:21 AM